Job Opportunities

The Department of Biological Sciences within the College of Arts and Sciences at the University at Albany invites applications for a full-time, tenure-track position at the rank of Assistant Professor in Quantitative Systems Neuroscience.

The Dong Lab is seeking a highly motivated researcher at the technician, research assistant, or postdoctoral level to join our team studying extracellular vesicle (EV) RNA biology in Parkinson’s disease. We are part of an NIH-funded multi-center effort to build a large EV transcriptome resource.

Qualifications:
• Bachelor’s, Master’s, or PhD in a relevant field (biology, neuroscience, molecular biology, etc.)
• Hands-on experience with RNA isolation and QC is required
• Experience with low-input RNA or RNA-seq is strongly preferred
• Strong organizational and communication skills; ability to work independently and in a team

To Apply: Please send your CV and a brief description of research experience to xianjun.dong@yale.edu.

The Department of Biochemistry and Molecular Biology in the University of Florida (UF) College of Medicine invites applications for a tenure-track appointment at the Assistant Professor level. The successful candidates must have a PhD or equivalent degree in Biochemistry, Molecular Biology, or broadly related field. The successful candidate(s) will conduct cutting-edge, exceptional research within the broadly constituted disciplines of Biochemistry and Molecular Biology that would synergize with the current UF research strengths. Demonstrated ability to obtain external funding will enhance the application. Exceptional candidates at the Associate Professor level will be considered.

The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology invites applications for two tenure-track open rank (Assistant, Associate, and Full Professor) faculty positions as part of the establishment of our new RNA Center. We seek exceptional scientists working at the interface of chemistry and biology, exploring fundamental and translational aspects of RNA structure, function, and therapeutic potential.

Cloverleaf Bio is an early-stage therapeutics company that is developing a new class of engineered tRNA therapeutics. Our tRNAs target an underappreciated vulnerability of cancer: addiction to high levels of tRNA modifying enzymes. Cloverleaf’s approach to drugging tRNA modifying enzymes uses engineered “trojan horse” tRNAs to modulate translation in cancerous cells. The programmability, potency, and specificity of our tRNAs gives us the potential to dramatically improve cancer treatment.